Cited by 50Liver Disease Diagnosis and TreatmentEstrogen and related hormone effectsLipid metabolism and biosynthesis

5α-Reductase Type 2 Regulates Glucocorticoid Action and Metabolic Phenotype in Human Hepatocytes

Open access
Nasiri, Maryam, Nikolaou, Nikolaos, Parajes, Silvia, Krone, Nils P., Valsamakis, George, Mastorakos, George, Hughes, Beverly, Taylor, Angela +3 more·2015·Endocrinology

Abstract

Glucocorticoids and androgens have both been implicated in the pathogenesis of nonalcoholic fatty liver disease (NAFLD); androgen deficiency in males, androgen excess in females, and glucocorticoid excess in both sexes are associated with NAFLD. Glucocorticoid and androgen action are regulated at a prereceptor level by the enzyme 5α-reductase type 2 (SRD5A2), which inactivates glucocorticoids to their dihydrometabolites and converts T to DHT. We have therefore explored the role of androgens and glucocorticoids and their metabolism by SRD5A2 upon lipid homeostasis in human hepatocytes. In both primary human hepatocytes and human hepatoma cell lines, glucocorticoids decreased de novo lipogenesis in a dose-dependent manner. Whereas androgen treatment (T and DHT) increased lipogenesis in cell lines and in primary cultures of human hepatocytes from female donors, it was without effect in primary hepatocyte cultures from men. SRD5A2 overexpression reduced the effects of cortisol to suppress lipogenesis and this effect was lost following transfection with an inactive mutant construct. Conversely, pharmacological inhibition using the 5α-reductase inhibitors finasteride and dutasteride augmented cortisol action. We have demonstrated that manipulation of SRD5A2 activity can regulate lipogenesis in human hepatocytes in vitro. This may have significant clinical implications for those patients prescribed 5α-reductase inhibitors, in particular augmenting the actions of glucocorticoids to modulate hepatic lipid flux.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/en.2015-1149

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Both T and DHT increase lipogenesis in human hepatocytes of female but not male donors.

    “Both T and DHT have recently been shown to increase lipogenesis in human hepatocytes of female (but not male) donors (Nasiri et al., 2015)”

    From Intracrine androgen biosynthesis, metabolism and action revisited (2018) · cites this paper as Nasiri et al., 2015

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Nasiri, M., Nikolaou, N., Parajes, S., Krone, N. P., Valsamakis, G., Mastorakos, G., Hughes, B., Taylor, A., Bujalska, I. J., Gathercole, L. L., & Tomlinson, J. W.
Affiliations
Churchill Hospital (GB)
Corresponding author
Tomlinson, Jeremy W.
Venue
Endocrinology
Published
2015-08
Volume
156
Issue
8
Pages
2863-2871
ISSN
  • 0013-7227 (ISSN-L)
  • 1945-7170
OpenAlex
W1845645347
Cited by
50
References
32
Citations by year
2026: 3 · 2025: 1 · 2024: 4 · 2023: 1 · 2022: 14 · 2021: 9 · 2020: 3 · 2019: 3 · 2018: 5 · 2017: 3 · 2016: 3 · 2015: 1
FWCI
3.14
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Endocrinology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
Keywords
5α-reductase type 2, SRD5A2, glucocorticoid activity, androgens, dihydrotestosterone, cortisol, de novo lipogenesis, hepatic lipid metabolism, non-alcoholic fatty liver disease, 5-alpha reductase inhibitors, finasteride, dutasteride, sex differences, human hepatocytes
MeSH terms
Adult, Aged, Androgens, Biological Transport, Cells, Cultured, Female, Glucocorticoids, Humans, Insulin, Male, Membrane Proteins, Middle Aged, Phenotype, 3-Oxo-5-alpha-Steroid 4-Dehydrogenase, Finasteride, Hepatocytes, Lipogenesis, 5-alpha Reductase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review